UK markets close in 1 hour 55 minutes
  • FTSE 100

    7,007.66
    -11.87 (-0.17%)
     
  • FTSE 250

    22,545.90
    +23.72 (+0.11%)
     
  • AIM

    1,255.96
    +1.71 (+0.14%)
     
  • GBP/EUR

    1.1597
    +0.0057 (+0.49%)
     
  • GBP/USD

    1.3956
    +0.0116 (+0.84%)
     
  • BTC-GBP

    40,414.68
    +1,174.28 (+2.99%)
     
  • CMC Crypto 200

    1,276.27
    -22.68 (-1.75%)
     
  • S&P 500

    4,178.30
    -7.17 (-0.17%)
     
  • DOW

    34,061.67
    -139.00 (-0.41%)
     
  • CRUDE OIL

    63.11
    -0.02 (-0.03%)
     
  • GOLD FUTURES

    1,769.20
    -11.00 (-0.62%)
     
  • NIKKEI 225

    29,685.37
    +2.00 (+0.01%)
     
  • HANG SENG

    29,106.15
    +136.44 (+0.47%)
     
  • DAX

    15,434.62
    -25.13 (-0.16%)
     
  • CAC 40

    6,314.07
    +27.00 (+0.43%)
     

Insights on the Respiratory Disease Diagnostics Global Market to 2026 - Transforming Healthcare Infrastructure in Emerging Markets Presents Opportunities

Research and Markets
·6-min read

Dublin, March 30, 2021 (GLOBE NEWSWIRE) -- The "Respiratory Disease Diagnostics Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2026" report has been added to ResearchAndMarkets.com's offering.

The report on the global respiratory disease diagnostics market provides qualitative and quantitative analysis for the period from 2018 to 2026. The report predicts the global respiratory disease diagnostics market to grow with a CAGR of 7.8% over the forecast period from 2020-2026. The study on respiratory disease diagnostics market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2018 to 2026.

The report on respiratory disease diagnostics market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global respiratory disease diagnostics market over the period of 2018 to 2026. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global respiratory disease diagnostics market over the period of 2018 to 2026. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers

  • Rise in the prevalence of respiratory diseases

  • Growing the geriatric population that is more susceptible to the respiratory diseases

2) Restraints

  • Lack of skilled professionals in low- and middle-income countries

3) Opportunities

  • Transforming healthcare infrastructure in emerging markets

Research Methodology

A) Primary Research
The primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders
2. Internal and External subject matter experts
3. Professionals and participants from the industry

The primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/country managers
5. Vice President level executives.

B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered
The global respiratory disease diagnostics market is segmented on the basis of product, disease, and end user.

The Global Respiratory Disease Diagnostics Market by Product

  • Instruments and Devices

  • Assays and Reagents

  • Services

The Global Respiratory Disease Diagnostics Market by Disease

  • Chronic Obstructive Pulmonary Disease

  • Asthma

  • Tuberculosis

  • Other Diseases

The Global Respiratory Disease Diagnostics Market by End User

  • Hospitals

  • Clinics

  • Reference Laboratories

  • Others

What does this Report Deliver?
1. Comprehensive analysis of the global as well as regional markets of the respiratory disease diagnostics market.
2. Complete coverage of all the segments in the respiratory disease diagnostics market to analyze the trends, developments in the global market and forecast of market size up to 2026.
3. Comprehensive analysis of the companies operating in the global respiratory disease diagnostics market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Key Topics Covered:

1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches

2. Executive Summary
2.1. Respiratory Disease Diagnostics Market Highlights
2.2. Respiratory Disease Diagnostics Market Projection
2.3. Respiratory Disease Diagnostics Market Regional Highlights

3. Global Respiratory Disease Diagnostics Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Analysis of COVID-19 impact on the Respiratory Disease Diagnostics Market
3.4. Porter's Five Forces Analysis
3.5. Growth Matrix Analysis
3.5.1. Growth Matrix Analysis by Product
3.5.2. Growth Matrix Analysis by Disease
3.5.3. Growth Matrix Analysis by End User
3.5.4. Growth Matrix Analysis by Region
3.6. Value Chain Analysis of Respiratory Disease Diagnostics Market

4. Respiratory Disease Diagnostics Market Macro Indicator Analysis

5. Global Respiratory Disease Diagnostics Market by Product
5.1. Instruments and Devices
5.2. Assays and Reagents
5.3. Services

6. Global Respiratory Disease Diagnostics Market by Disease
6.1. Chronic Obstructive Pulmonary Disease
6.2. Asthma
6.3. Tuberculosis
6.4. Other Diseases

7. Global Respiratory Disease Diagnostics Market by End User
7.1. Hospitals
7.2. Clinics
7.3. Reference Laboratories
7.4. Others

8. Global Respiratory Disease Diagnostics Market by Region 2020-2026
8.1. North America
8.1.1. North America Respiratory Disease Diagnostics Market by Product
8.1.2. North America Respiratory Disease Diagnostics Market by Disease
8.1.3. North America Respiratory Disease Diagnostics Market by End User
8.1.4. North America Respiratory Disease Diagnostics Market by Country
8.2. Europe
8.2.1. Europe Respiratory Disease Diagnostics Market by Product
8.2.2. Europe Respiratory Disease Diagnostics Market by Disease
8.2.3. Europe Respiratory Disease Diagnostics Market by End User
8.2.4. Europe Respiratory Disease Diagnostics Market by Country
8.3. Asia-Pacific
8.3.1. Asia-Pacific Respiratory Disease Diagnostics Market by Product
8.3.2. Asia-Pacific Respiratory Disease Diagnostics Market by Disease
8.3.3. Asia-Pacific Respiratory Disease Diagnostics Market by End User
8.3.4. Asia-Pacific Respiratory Disease Diagnostics Market by Country
8.4. RoW
8.4.1. RoW Respiratory Disease Diagnostics Market by Product
8.4.2. RoW Respiratory Disease Diagnostics Market by Disease
8.4.3. RoW Respiratory Disease Diagnostics Market by End User
8.4.4. RoW Respiratory Disease Diagnostics Market by Sub-region

9. Company Profiles and Competitive Landscape
9.1. Competitive Landscape in the Global Respiratory Disease Diagnostics Market
9.2. Companies Profiled
9.2.1. Becton, Dickinson and Company
9.2.2. Koninklijke Philips N.V.
9.2.3. Medtronic, PLC
9.2.4. MGC Diagnostics Corporation
9.2.5. Abbott Laboratories
9.2.6. Thermo Fisher Scientific Inc.
9.2.7. CAREstream Medical Ltd
9.2.8. ResMed Company
9.2.9. bioMerieux SA
9.2.10. COSMED S.r.l.

For more information about this report visit https://www.researchandmarkets.com/r/kpblvf

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900